The global Surgical Tourniquets Market is estimated to be valued at US$ 518.52 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Surgical tourniquets refer to compression devices that cut off arterial and venous circulation in a limb temporarily during surgery. They help in maintaining a nearly bloodless surgical field and are commonly used in orthopedic, trauma and arterial surgeries. Tourniquets provide cost-effective and convenient way to create a bloodless field for surgery.
Market key trends:
One of the key trends in the surgical tourniquets market is the development and launch of next generation tourniquet systems. Manufacturers are developing technologically advanced tourniquet systems to provide improved safety and efficacy. For instance, in 2018, Zimmer Biomet launched the Zimmer Biomet EST Tourniquet System which is an electrically powered, single-use, computer-controlled tourniquet that allows remote monitoring and documentation of cuff pressure and provides cuff pressure alerts. Similarly, in 2017, Delfi medical innovations inc. launched the next generation Delfi triple tourniquet cuff system which provides improved safety features and ease of use for orthopedic surgeons.
Read More Insights @ https://www.coherentmarketinsights.com/market-insight/surgical-tourniquets-market-1736
SWOT Analysis
Strength: Surgical tourniquets help prevent blood loss during surgery, allowing surgeons better visibility and control. They reduce risks associated with transfusions and complications from blood loss.
Weakness: Over-tightening of tourniquets can damage nerves and soft tissues. Improper application may cause complications and lead to mistakes during surgery.
Opportunity: Growing number of surgical procedures performed globally due to rising incidences of chronic diseases, accidents, and traumas. Increasing demand for minimally invasive and safer surgeries presents market opportunities.
Threats: Alternative hemostatic techniques like diathermy and bipolar vessel sealing pose threat to tourniquets market. High costs of advanced tourniquet systems can limit their adoption in price-sensitive regions.
Key Takeaways
The global surgical tourniquets market size is expected to witness high growth, exhibiting a CAGR of 7.8% over the forecast period, due to increasing number of surgical procedures performed worldwide. As per the Agency for Healthcare Research and Quality, over 90 million inpatient and outpatient surgeries were performed across the U.S. in 2019.
Regional analysis: North America dominates the global surgical tourniquets market and is expected to continue its leading position during the forecast period. This is attributed to factors such as rising prevalence of chronic diseases, growing number of ambulatory surgery centers, increasing adoption of technologically advanced products, and presence of major players in the region. Asia Pacific surgical tourniquets market is poised to exhibit fastest growth during 2023-2030, attributed to improving healthcare infrastructure, and rising medical tourism in countries such as India, China, and Indonesia.
Key players operating in the surgical tourniquets market include Zimmer Biomet, Stryker Corporation, Delfi medical innovations inc., Hammarplast Medical AB, OHK Medical Devices Inc., Pyng Medical Corp., Beijing Jinxinxing Medical Device Factory, SourceMark, and AneticAid. Major players are focusing on new product launches, geographical expansion and acquisitions to consolidate their market presence. In August 2022, Zimmer Biomet launched the Compact tourniquet cuff which offers better soft tissue protection and patient comfort.